Abstract
A virulence-encoding plasmid, p15WZ-82_Vir, which formed as a result of the integration of a 100-kb fragment of the hypervirulence plasmid pLVPK into a conjugative IncFIB plasmid, was recovered from a clinical Klebsiella variicola strain. Such a plasmid could be conjugated to carbapenem-resistant Klebsiella strains, enabling them to simultaneously express the carbapenem resistance- and hypervirulence-associated phenotypes. Unlike the non-conjugative pLVPK plasmid, emergence of p15WZ-82_Vir may promote rapid dissemination of virulence-encoding elements among Gram-negative bacterial pathogens.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Fusion plasmid enhanced the endemic extensively drug resistant Klebsiella pneumoniae clone ST147 harbored blaOXA-48 to acquire the hypervirulence and cause fatal infection
Annals of Clinical Microbiology and Antimicrobials Open Access 14 February 2023
-
Convergence of two serotypes within the epidemic ST11 KPC-producing Klebsiella pneumoniae creates the “Perfect Storm” in a teaching hospital
BMC Genomics Open Access 07 October 2022
-
Mobilization of the nonconjugative virulence plasmid from hypervirulent Klebsiella pneumoniae
Genome Medicine Open Access 22 July 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

Data availability
Complete sequences of the chromosome of strain 15WZ-82, and those of the p15WZ-82_Vir, p15WZ-82_KPC and p15WZ-82_res plasmids, have been deposited with the GenBank databases under accession nos. CP032354, CP032355, CP032356 and CP032357. All other data related to this study are available upon request.
References
Paczosa, M. K. & Mecsas, J. Microbiol. Mol. Biol. Rev. 80, 629–661 (2016).
Shon, A. S. & Russo, T. A. Future Microbiol. 7, 669–671 (2012).
Zhang, Y. et al. J. Infect. 71, 553–560 (2015).
Li, W. et al. Clin. Infect. Dis. 58, 225–232 (2014).
Gu, D. et al. Lancet Infect. Dis. 18, 37–46 (2018).
Hopkins, K. L. et al. J. Antimicrob. Chemother. 72, 2129–2131 (2017).
Zurfluh, K., Poirel, L., Nordmann, P., Klumpp, J. & Stephan, R. Antimicrob. Resist. Infect. Control 4, 38 (2015).
Diancourt, L., Passet, V., Verhoef, J., Grimont, P. A. & Brisse, S. J. Clin. Microbiol. 43, 4178–4182 (2005).
Brisse, S. et al. J. Clin. Microbiol. 51, 4073–4078 (2013).
Chen, Y. T. et al. Gene 337, 189–198 (2004).
Taylor, D. E. et al. J. Bacteriol. 184, 4690–4698 (2002).
Weinstein, M. P. M100 Performance Standards for Antimicrobial Susceptibility Testing (Clinical and Laboratory Standards Institute, 2018).
Wick, R. R., Judd, L. M., Gorrie, C. L. & Holt, K. E. PLoS Comput. Biol. 13, e1005595 (2017).
Brettin, T. et al. Sci. Rep. 5, 8365 (2015).
Seemann, T. Bioinformatics 30, 2068–2069 (2014).
Wyres, K. L. et al. Microb. Genom. 2, e000102 (2016).
Alikhan, N. F., Petty, N. K., Ben Zakour, N. L. & Beatson, S. A. BMC Genomics 12, 402 (2011).
Sullivan, M. J., Petty, N. K. & Beatson, S. A. Bioinformatics 27, 1009–1010 (2011).
Huang, Y. et al. Antimicrob. Agents Chemother. 60, 4364–4368 (2016).
McLaughlin, M. M. et al. BMC Infect. Dis. 14, 31 (2014).
Zhang, R. et al. Antimicrob. Agents Chemother. 60, 709–711 (2016).
Palacios, M. et al. mBio 9, e01443-18 (2018).
Shon, A. S., Bajwa, R. P. & Russo, T. A. Virulence 4, 107–118 (2013).
Acknowledgements
We thank K. Chen, C. Yang and Z. Zheng from our laboratory for their help with the PFGE and animal experiments, and L. Ye and N. Dong for their assistance with the sequencing experiments. We thank K.-Y. Yuen for providing the clinical K. pneumoniae strains. This study was funded by the Collaborative Research Fund from the Research Grant Council of the Government of Hong Kong Special Administrative Region (no. C5026-16G) and the Research Impact Fund (no. R5011-18F).
Author information
Authors and Affiliations
Contributions
X.Y. designed the study, performed strain characterization, sequencing, conjugation assay, greater wax moth infection model, mucoviscosity and capsule production assays and drafted the manuscript. E.W.-C.C. designed the study and edited the manuscript. R.Z. participated in study design and strain collection. S.C. designed the study, supervised the whole project and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Table 1 and Supplementary Figs. 1–5.
Rights and permissions
About this article
Cite this article
Yang, X., Wai-Chi Chan, E., Zhang, R. et al. A conjugative plasmid that augments virulence in Klebsiella pneumoniae. Nat Microbiol 4, 2039–2043 (2019). https://doi.org/10.1038/s41564-019-0566-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-019-0566-7
This article is cited by
-
Fusion plasmid enhanced the endemic extensively drug resistant Klebsiella pneumoniae clone ST147 harbored blaOXA-48 to acquire the hypervirulence and cause fatal infection
Annals of Clinical Microbiology and Antimicrobials (2023)
-
Convergence of two serotypes within the epidemic ST11 KPC-producing Klebsiella pneumoniae creates the “Perfect Storm” in a teaching hospital
BMC Genomics (2022)
-
An integrated IncFIB/IncFII plasmid confers hypervirulence and its fitness cost and stability
European Journal of Clinical Microbiology & Infectious Diseases (2022)
-
Mobilization of the nonconjugative virulence plasmid from hypervirulent Klebsiella pneumoniae
Genome Medicine (2021)
-
Population genomics of Klebsiella pneumoniae
Nature Reviews Microbiology (2020)